Arielle Bogorad, Progyny SVP, Employer Market Strategy and Services

Release Date:

In 2017, Arielle Bogorad was diagnosed with unexplained infertility and, after more than a year of trying IVF drugs, she was told she was a “poor responder” to them and would have a hard time achieving chromosomally normal embryos. Today, Ali talks to her about her family building journey, including how, in 2019, she was able to obtain 2 normal embryos with one being transferred and resulting in her having a beautiful baby girl that September. The exorbitant cost of fertility treatment would have been too expensive for Arielle and her family, but she was able to move forward and have her daughter because her employer offered Progyny. Arielle explains to Ali why she joined Progyny in a role where she educates employers on how critical family building benefits are, the impact they have on DEI initiatives, and the cultural message it sends to employees. She also talks about how the trauma and grief of infertility lives on. 
For more, check out https://progyny.com/

TOPICS COVERED IN THIS EPISODE:
Unexplained infertility; IVF; cancelled cycles; trauma; frozen embryos; chromosomally abnormal embryos; fertility insurance and benefits; advocacy; grief

For sponsorship or partnership inquiries, please email infertileafstories@gmail.com

EPISODE SPONSORS:
FERTILITY RALLY @fertilityrally www.fertilityrally.com
No one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 4 to 5 support groups per week, 4 private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.

Join now at link in bio on IG @fertilityrally or at www.fertilityrally.com

RECEPTIVA DX
ReceptivaDx is the only test that can identify endometriosis, progesterone resistance and endometritis in a single sample, all causes for unexplained infertility and thus success rates of IVF treatments. ReceptivaDx includes BCL6, a marker that identifies uterine inflammation most often associated with asymptomatic (silent) endometriosis. BCL6 is found in more than 50% of women with unexplained infertility and over 65% of women with two or more IVF failures. If positive for the ReceptivaDx test, treatment options can improve the chances for a successful live birth 5 fold! Learn more at receptivadx.com or download our app “Receptivadx" -- and USE CODE INFERTILEAF23 for $75 off the test

Fertility Coach Academy and Elizabeth King Fertility Coaching
Ready to turn your passion for fertility into a purpose-driven career? Visit www.fertilitycoachacademy.com. You’ll be empowered to make a difference, while embracing the mind, body, and spirit approach. Or are you seeking personalized guidance on your own journey. Visit www.elizabethking.com. Unleash your potential and unlock the doors to parenthood.

Use code "InfertileAF" on both for your special 25% discount.
Support this podcast at: https://redcircle.com/infertile-af/donations
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
Support this podcast at — https://redcircle.com/infertile-af/donationsAdvertising Inquiries: https://redcircle.com/brands
Learn more about your ad choices. Visit podcastchoices.com/adchoices

Arielle Bogorad, Progyny SVP, Employer Market Strategy and Services

Title
Arielle Bogorad, Progyny SVP, Employer Market Strategy and Services
Copyright
Release Date

flashback